Tag: SAVE
Two-year trial results support sirolimus-eluting balloon for patients with failing AVFs
Treatment with a sustained-release sirolimus-eluting balloon (SLR) for patients with failing arteriovenous fistulas (AVFs) was associated with higher target-lesion primary patency (TLPP) through to...
Retrospective study finds 97% success rate with Surfacer Inside-Out access catheter
The Surfacer Inside-Out Access Catheter System (Bluegrass Vascular) has demonstrated positive commercial use, consistently achieving central venous access in patients with upper body occlusions....
First patients enrolled in Bluegrass Vascular post-market SAVE study
Bluegrass Vascular Technologies has enrolled over one third of its patients in the company's post-market SAVE (Surfacer System to Facilitate Access in Venous Occlusions)...
